COMPANY

Integra LifeSciences

HQ: Princeton, NJ source · integralife.com ↗ · Mid-Atlantic

FDA-cleared device company Past trials only

Location: Princeton, NJ · source · Oct 13, 2026

Profile checked Oct 10, 2026

Keywords: Diabetic Foot Ulcer Hydrocephalus Otitis Media Sinusitis Chronic Sinusitis Necrotizing Soft Tissue Infection NPH (Normal Pressure Hydrocephalus) IIH - Idiopathic Intracranial Hypertension Ventral Hernia Otitis Media With Effusion Acute Otitis Media Recurrent Acute Rhinosinusitis Chronic Rhinosinusitis Burn Injury Burn Scar Burn Wounds - Partial Thickness (2nd Degree) Skin Grafting Tissue Repair Soft Tissue Reconstruction Wound Management Pressure Ulcer Fournier's Gangrene Pilonidal Cyst Open Abdomen Hidradenitis Suppurativa Lower Extremity Wound Incisional Venous Leg Ulcer Dysfunction of Eustachian Tube Pressure Injury Venous Ulcer Diabetic Ulcers Draining Wound Brain Tumor Post-Traumatic Hydrocephalus Hemorrhagic Stroke Supratentorial Hemorrhage Intraventricular Hemorrhage

82Trials (company is sponsor)2FDA records (2 yrs)4NIH grants

Timeline

Oct 2, 2026 Debt Debt: $600M (not counted as a raise), announced Oct 2, 2026. Source: company release on GlobeNewswire. source ↗
Aug 31, 2026 Trial start —: Urinary Bladder Matrix (UBM) Registry source ↗
Oct 8, 2025 FDA FDA 510(k) clearance: CUSA® Clarity Ultrasonic Surgical Aspirator System — K251162, Oct 8, 2025. Applicant at approval: Integra LifeSciences Corporation. source ↗
Jun 17, 2025 Trial start —: AERA Pediatrics Registry source ↗
Apr 9, 2025 FDA FDA 510(k) clearance: AURORA® Surgiscope® System (ASX15/60); AURORA® Surgiscope® System (ASX15/80) — K250752, Apr 9, 2025. Applicant at approval: Integra LifeSciences Corporation. source ↗
Mar 1, 2025 Trial start —: Tissue Quality of Integra vs. BTM Treated Burns source ↗
Dec 12, 2024 Trial start Not phased (device or behavioral study): MicroMatrix® Flex in Tunneling Wounds source ↗
Nov 18, 2024 Trial start Not phased (device or behavioral study): A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers source ↗
Sep 29, 2024 Trial start —: Bactiseal Catheter Safety Registry Study source ↗
Feb 23, 2024 Trial start —: Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study source ↗
Sep 12, 2023 Trial start —: T-GENVIH-003 LTFU (Long Term Follow Up) Study source ↗
2023-06 Trial start —: The CUSA Clarity Bone Tip Study source ↗
Mar 3, 2023 Trial start —: External Ventricular Drainage Post-Market Clinical Follow-up Registry source ↗
Jan 24, 2023 Trial start —: Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve source ↗
Nov 22, 2022 Trial start —: Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair source ↗
May 30, 2022 Trial start —: REINVENT Registry (Registry of the Nerve Gap Repair From Integra) source ↗
May 15, 2022 Trial start Not phased (device or behavioral study): NeuraGen 3D Pilot Study source ↗
Jan 31, 2022 Trial start —: The SurgiMend PRS Retrospective Study source ↗
Sep 15, 2021 Trial start Not phased (device or behavioral study): The Purpose of This Study is to Determine Whether CerebroFlo™ EVD Catheter is Effective During the Treatment of Intraventricular Hemorrhage (IVH) source ↗
2021-09 Trial start Not phased (device or behavioral study): AmnioExcel® Plus vs SOC in the Management of Diabetic Foot Ulcers source ↗
Apr 28, 2021 Trial start —: Suturable DuraGen™ PMCF Study source ↗
Oct 23, 2020 Trial start —: The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation source ↗
Sep 1, 2020 Trial start —: Bactiseal Catheter Safety Registry in China source ↗
May 2, 2020 Trial start —: A Study on the Safety of Hakim Programmable Shunt System source ↗
Mar 30, 2020 Trial start —: The CUSA Clarity Soft Tissue Removal Study source ↗

Showing 25 of 53 dated events.

Upcoming milestones

Dec 31, 2026 (ESTIMATED) · Not phased · A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers · NCT06453187
Oct 15, 2028 (ESTIMATED) · · The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation · NCT04494295
Jan 24, 2029 (ESTIMATED) · · Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve · NCT05397106
Aug 31, 2029 (ESTIMATED) · · Urinary Bladder Matrix (UBM) Registry · NCT07805798
2030-10 (ESTIMATED) · · AERA Pediatrics Registry · NCT07071298

Estimated primary completion per ClinicalTrials.gov. Dates move.

Funding

Debt: $600.0M. Last 2 years.

Oct 2, 2026 Debt: $600M (not counted as a raise), announced Oct 2, 2026. Source: company release on GlobeNewswire. source ↗

Clinical trials (lead sponsor) Showing 50 of 82

Record	Title	Phase	Status	Start	Primary completion
NCT06760611	Tissue Quality of Integra vs. BTM Treated Burns	Not listed	Withdrawn	Mar 1, 2025	Sep 30, 2025 (actual)
NCT07805798	Urinary Bladder Matrix (UBM) Registry	Not listed	Not yet recruiting	Aug 31, 2026	Aug 31, 2029 (estimated)
NCT06453187	A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers	Not phased (device or behavioral study)	Enrolling by invitation	Nov 18, 2024	Dec 31, 2026 (estimated)
NCT07071298	AERA Pediatrics Registry	Not listed	Recruiting	Jun 17, 2025	2030-10 (estimated)
NCT06629506	MicroMatrix® Flex in Tunneling Wounds	Not phased (device or behavioral study)	Completed	Dec 12, 2024	Aug 31, 2025 (actual)
NCT05397106	Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve	Not listed	Active, not recruiting	Jan 24, 2023	Jan 24, 2029 (estimated)
NCT04494295	The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation	Not listed	Recruiting	Oct 23, 2020	Oct 15, 2028 (estimated)
NCT05652296	External Ventricular Drainage Post-Market Clinical Follow-up Registry	Not listed	Completed	Mar 3, 2023	Dec 16, 2024 (actual)
NCT05113381	The Purpose of This Study is to Determine Whether CerebroFlo™ EVD Catheter is Effective During the Treatment of Intraventricular Hemorrhage (IVH)	Not phased (device or behavioral study)	Completed	Sep 15, 2021	Jul 31, 2025 (actual)
NCT06034652	T-GENVIH-003 LTFU (Long Term Follow Up) Study	Not listed	Completed	Sep 12, 2023	Jan 19, 2024 (actual)
NCT04923867	Suturable DuraGen™ PMCF Study	Not listed	Completed	Apr 28, 2021	Jul 31, 2024 (actual)
NCT05182177	The SurgiMend PRS Retrospective Study	Not listed	Completed	Jan 31, 2022	Dec 31, 2024 (actual)
NCT06276543	Bactiseal Catheter Safety Registry Study	Not listed	Recruiting	Sep 29, 2024	Jul 31, 2026 (estimated)
NCT06297187	Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study	Not listed	Completed	Feb 23, 2024	Jul 31, 2024 (actual)
NCT01324271	inVENT-In-Office Study	Not phased (device or behavioral study)	Completed	2011-01	2012-05 (actual)
NCT01496287	Tympanostomy Tube Placement in Children in the Office (Inova Study)	Not phased (device or behavioral study)	Completed	2011-12	2012-04 (actual)
NCT01202578	Evaluation of the Tympanostomy Tube Delivery System	Phase 2/Phase 3	Completed	2010-09	2010-11 (actual)
NCT01054703	Clinical Evaluation of the Ethmoid Sinus Spacer	Not phased (device or behavioral study)	Terminated	Apr 1, 2007	Nov 1, 2007 (actual)
NCT00939796	Clinical Study of the Tympanostomy Tube Delivery System	Not phased (device or behavioral study)	Completed	2009-03	2009-06 (actual)
NCT00791934	Clinical Study of Safety and Efficacy for the Relieva Stratus With Elution of Triamcinolone Acetonide	Not phased (device or behavioral study)	Completed	2008-08	2011-11 (actual)
NCT01046877	Singapore Tympanostomy Tube Delivery System Study	Not phased (device or behavioral study)	Completed	2008-12	2010-08 (actual)
NCT01107379	Optimization and Refinement of Technique in In-Office Sinus Dilation 2	Not listed	Completed	2010-04	2012-01 (actual)
NCT00231062	Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranasal Sinuses (CLEAR)	Phase 3	Completed	2005-04	2006-06 (actual)
NCT01714687	Comparison of Balloon Sinuplasty In-Office Versus Medical Management for Recurrent Acute Sinusitis Patients (CABERNET)	Not phased (device or behavioral study)	Completed	Oct 1, 2012	Oct 1, 2015 (actual)
NCT01685229	Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis	Not listed	Completed	Sep 1, 2012	Apr 1, 2015 (actual)
NCT02150044	Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion	Not phased (device or behavioral study)	Completed	2010-02	2010-10 (actual)
NCT00941993	Anesthetic Effect of Lidocaine/Epinephrine Solution Delivered Via Iontophoresis to External Auditory Apparatus	Not phased (device or behavioral study)	Completed	2008-04	2011-01 (actual)
NCT00939393	Balloon Sinus Dilation In Office or OR	Not phased (device or behavioral study)	Completed	Apr 1, 2008	Jun 1, 2009 (actual)
NCT02087150	Study of Safety and Efficacy for the Eustachian Tube Balloon Catheter	Not phased (device or behavioral study)	Completed	Feb 1, 2014	Dec 1, 2016 (actual)
NCT00939471	Safety and Efficacy of Balloon Sinuplasty in Pediatric Sinusitis	Not phased (device or behavioral study)	Completed	Apr 1, 2007	Jul 1, 2009 (actual)
NCT02347943	Global Sinus Surgery Registry	Not listed	Terminated	Jan 1, 2015	Nov 1, 2015 (actual)
NCT01444391	inVENT-visIOn Study	Not phased (device or behavioral study)	Completed	2011-10	2012-05 (actual)
NCT01047904	Anesthetizing the Tympanic Membrane in Healthy Volunteers	Not phased (device or behavioral study)	Completed	2009-08	2009-11 (actual)
NCT01346332	Healthy Volunteer Study	Not listed	Completed	Apr 1, 2011	Feb 1, 2012 (actual)
NCT01455948	Canadian Health Economics, Outcome, and Effectiveness Comparison of Treatment in Patients With Chronic Rhinosinusitis	Not phased (device or behavioral study)	Terminated	2012-02	2012-11 (actual)
NCT05339594	REINVENT Registry (Registry of the Nerve Gap Repair From Integra)	Not listed	Terminated	May 30, 2022	Jun 3, 2024 (actual)
NCT01611246	Earset Healthy Volunteer Study	Not listed	Completed	May 1, 2012	Aug 1, 2012 (actual)
NCT05610267	Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair	Not listed	Completed	Nov 22, 2022	Dec 28, 2022 (actual)
NCT05343143	NeuraGen 3D Pilot Study	Not phased (device or behavioral study)	Terminated	May 15, 2022	Jul 11, 2023 (actual)
NCT01612806	A Multi-center, Prospective, Randomized Study With PriMatrix and PriMatrix Ag for the Treatment of Venous Leg Ulcers	Not phased (device or behavioral study)	Terminated	2011-06	2017-02 (actual)
NCT04300075	The CUSA Clarity Bone Tip Study	Not listed	Withdrawn	2023-06	2024-08 (estimated)
NCT04496414	Bactiseal Catheter Safety Registry in China	Not listed	Completed	Sep 1, 2020	Nov 30, 2020 (actual)
NCT03010319	PriMatrix for the Management of Diabetic Foot Ulcers	Not phased (device or behavioral study)	Completed	2017-01	2020-08 (actual)
NCT02021279	ACell MatriStem Pelvic Floor Matrix Versus Native Tissue Repair, Comparative Study	Not phased (device or behavioral study)	Completed	Jun 11, 2014	Apr 28, 2021 (actual)
NCT04298268	The CUSA Clarity Soft Tissue Removal Study	Not listed	Completed	Mar 30, 2020	Nov 24, 2021 (actual)
NCT04207229	CERTAS Programmable Valve Registry	Not listed	Completed	Nov 21, 2019	Nov 18, 2021 (actual)
NCT03816202	Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF)	Not listed	Completed	Apr 25, 2019	Aug 27, 2019 (actual)
NCT04285489	A Study on the Safety of Hakim Programmable Shunt System	Not listed	Completed	May 2, 2020	Jul 28, 2020 (actual)
NCT05024656	AmnioExcel® Plus vs SOC in the Management of Diabetic Foot Ulcers	Not phased (device or behavioral study)	Withdrawn	2021-09	2024-02 (estimated)
NCT03626623	Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care	Not phased (device or behavioral study)	Terminated	May 21, 2019	Feb 18, 2020 (actual)

FDA records (last 2 years)

Oct 8, 2025 FDA 510(k) clearance: CUSA® Clarity Ultrasonic Surgical Aspirator System — K251162, Oct 8, 2025. Applicant at approval: Integra LifeSciences Corporation. source ↗
Apr 9, 2025 FDA 510(k) clearance: AURORA® Surgiscope® System (ASX15/60); AURORA® Surgiscope® System (ASX15/80) — K250752, Apr 9, 2025. Applicant at approval: Integra LifeSciences Corporation. source ↗

NIH awards 4

Annual award amounts. Total $574K.

Jul 29, 1999 NIH award 1R44GM059531-01 FY1999: $251,148 awarded for that fiscal year; activity R44 (SBIR); PI CAHN, FREDERICK; recipient as written: INTEGRA LIFESCIENCES CORPORATION, PLAINSBORO, NJ. PEPTIDE ENHANCED ARTIFICIAL SK source ↗
Jul 26, 1999 NIH award 1R43GM060084-01 FY1999: $122,809 awarded for that fiscal year; activity R43 (SBIR); PI KEMNITZER, JOHN E; recipient as written: INTEGRA LIFESCIENCES CORPORATION, PLAINSBORO, NJ. GAS BLOWN RESORBABLE BIOMATE source ↗
Apr 7, 1997 NIH award 1R41NS036091-01 FY1997: $99,998 awarded for that fiscal year; activity R41 (STTR); PI BATRA, SURENDRA; recipient as written: INTEGRA LIFESCIENCES CORPORATION, PLAINSBORO, NJ. NERVE REGENERATION USING MAGNET source ↗
Jun 29, 1995 NIH award 1R43NS034224-01 FY1995: $99,990 awarded for that fiscal year; activity R43 (SBIR); PI BATRA, SURENDRA; recipient as written: INTEGRA LIFESCIENCES CORPORATION, PLAINSBORO, NJ. CAVERNOSAL NERVE REPAIR FOLLOWI source ↗

Connect

See your connections at Integra LifeSciences on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12